Millions more people may need to start cholesterol-lowering medications as young as their 30s. Here’s why

March 13, 2026 - 19:28

Millions more adults should consider starting cholesterol-lowering medications earlier in life, potentially in their 30s or 40s, to substantially reduce long-term risk of heart attack and stroke. This shift is based on updated medical guidance emphasizing a proactive, lifetime approach to cardiovascular health.

The rationale centers on the cumulative damage caused by elevated "bad" LDL cholesterol over decades. New research indicates that even moderately high levels, when sustained over many years, can significantly contribute to plaque buildup in arteries. By starting medication earlier, the goal is to prevent this buildup from ever reaching dangerous levels, rather than trying to reverse it later.

This represents a fundamental change in strategy for many practitioners. Previously, medication decisions were often based on shorter-term risk assessments focused on the next decade. The updated perspective considers a patient's projected risk over a 30-year horizon, which can identify younger individuals who would benefit from early intervention.

Statins remain the primary recommended medication. Experts stress that this advice is paired with the continued importance of lifestyle foundations: a heart-healthy diet, regular physical activity, and not smoking. The updated guidance aims to empower patients and doctors to make more personalized, preventive decisions for long-term well-being.